Related Experiment Video
Updated: Jul 18, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
MafB negatively regulates RANKL-mediated osteoclast differentiation
Kabsun Kim1, Jung Ha Kim, Junwon Lee
1Research Institute of Medical Sciences and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Hak-Dong 5, Dong-Ku, Gwangju 501-746, Korea.
MafB negatively regulates osteoclast formation induced by RANKL. Overexpressing MafB inhibits osteoclast differentiation by interfering with key transcription factors, revealing its role in bone remodeling.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Receptor activator of nuclear factor kappaB ligand (RANKL) is crucial for osteoclast differentiation from hematopoietic cells.
- Osteoclastogenesis involves complex regulation by various transcription factors.
Purpose of the Study:
- To investigate the role of MafB in RANKL-induced osteoclast differentiation.
- To elucidate the molecular mechanisms by which MafB modulates osteoclastogenesis.
Main Methods:
- Overexpression of MafB in bone marrow-derived monocyte/macrophage lineage cells (BMMs).
- RNA interference (RNAi) to reduce MafB expression.
- Analysis of osteoclast formation (TRAP+ multinuclear cells).
- Assessment of gene expression (NFATc1, OSCAR) and protein interactions.
Main Results:
- RANKL significantly reduces MafB expression during osteoclastogenesis.
- MafB overexpression inhibits osteoclast formation while preserving phagocytic activity.
- MafB attenuates the induction of NFATc1 and OSCAR.
- MafB interferes with the DNA-binding of c-Fos, Mitf, and NFATc1, inhibiting their transactivation.
- Reduced MafB expression enhances osteoclastogenesis and NFATc1/OSCAR expression.
Conclusions:
- MafB acts as a negative regulator of RANKL-induced osteoclast differentiation.
- MafB modulates osteoclastogenesis by interfering with key transcription factors like NFATc1 and OSCAR.
- MafB is an important modulator in RANKL-mediated bone remodeling processes.
Related Concept Videos
Osteoclasts in Bone Remodeling
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Master Transcription Regulators
Bone Remodeling
